1. A Study of the Regulations of the Re-evaluation Skills and Evaluation Modes for Drugs sold on the Market;Yan;Chinese Journal of Pharmacoepidemiology,2003
2. 2. The SFDA. Adverse Drug Reaction Information Bulletin, 1st issue. [2009-12-5]. Available from: URL: http://www.cdr.gov.cn/gxzy/ypblfytb/1373.shtml.
3. 3. The SFDA. Adverse Drug Reaction Information Bulletin. The 22th issue.[2009-12-5]. Available from: URL: http://www.cdr.gov.cn/gxzy/ypblfytb/8701.shtml.
4. 4. The SFDA. Emergency Notice from the State Food and Drug Administration to Suspend Use and Sales of Shuanghuanglian Injection manufactured by Jiamusi Branch, Wusulijiang Pharmaceutical Company, Heilongjiang.[2009-12-5]. Available from: URL: http://www.sda.gov.cn/WS01/CL0056/35813.html.
5. 5. The SFDA. Notice from the State Food and Drug Administration to Suspend Use and Sales of Shuanghuanglian Injection Labeled by Manufacturer Duoduo Pharmaceutical Co., Ltd.[2009-12-5] Available from: URL: http://www.cdr.gov.cn/xwdt/gnxw/11152.shtml.